Abstract
The European market includes Austria, Benelux, France, Germany, Italy, Poland,
Portugal, Scandinavia, Spain, Switzerland, and the United Kingdom. In 2007,
the combined European market for dental bone graft substitutes and other
biomaterials was valued at nearly €293 million. This is more than double
the value of the U.S. market. The difference between U.S. and European market
sizes is exacerbated by higher European prices and the falling value of the
U.S. dollar. The market is expected to grow at a double digit rate over the
forecast period, driven by the market for dental implants. By 2014, the
combined market is expected to reach nearly €800 million.
View Cart
